Helminth Induced Immunomodulation against Metainflammation and Insulin Resistance by Aravindhan, Vivekanandhan & Manohar, Sibi Joy
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors




the world’s leading publisher of
Open Access books









Metainflammation and Insulin 
Resistance
Vivekanandhan Aravindhan and Sibi Joy Manohar
Abstract
Filariasis mediated immunomodulation against metabolic diseases is a recently 
identified novel phenomenon. There seems to be an inverse relationship between 
filarial infections and type-2 diabetes. Rapid elimination of filarial diseases, due to 
mass drug administration has somehow fueled the sudden and rampant increase 
in type-2 diabetes, at least in certain tropical countries, like India and Indonesia. 
Filarial infections are in a way unique, since they bring about immunomodulation, 
in contrast to inflammation which is triggered by viral and bacterial infections. This 
dampens immunity and confers better survival for the pathogen. However, this also 
attenuates chronic inflammation and insulin resistance and thereby confers protec-
tion against type-2 diabetes. This chapter elucidates the various immune mecha-
nisms involved in immunomodulation against insulin resistance and type-2 diabetes 
induced by helminth infection.
Keywords: Metainflammation, Insulin Resistance, Immunomodulation,  
Helminth infections, Metabolic diseases
1. Introduction
1.1 What is metainflammation?
Chronic inflammation has long been recognized as a major etiological factor for 
metabolic diseases [1]. The inflammation in metabolic diseases is chronic, low grade 
and non-antigen-specific but differs from one condition to other [2]. This is differ-
ent from those seen in infectious diseases and has been named “Metainflammation”. 
Meta inflammation leads to insulin resistance (IR) wherein the target organs of 
insulin become resistant to insulin action [2]. IR has now been identified as a major 
etiological factor for a variety of metabolic diseases, apart from obesity and Type-2 
diabetes (T2DM) [2]. Meta inflammation typically starts as an organ-specific 
inflammation affecting the major target organs of insulin namely adipose tissue, 
skeletal muscles and liver [2]. With disease progression, it becomes more systemic 
and starts affecting the blood vessels leading to endothelial dysfunction called 
vasculopathy [2]. The exact cause of inflammation in IR is not clearly known even 
though dietary, genetic and environmental factors have been implicated [2].
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1.2 Helminth infection as an immunomodulation strategy
Infections serve as an important source of inflammation especially in tropical 
countries and can serve as a link between infections and metabolic diseases [3]. The 
link between infections and metabolic diseases is less well explored and in recent 
years has gained tremendous interest [3]. Changes in the lifestyle of people living 
in industrialized countries have led to a decrease in the infectious burden and an 
increase in the prevalence of allergic and autoimmune diseases [4]. The leading idea 
is that some infectious agents – notably those that co-evolved with us – are able to 
protect us against a large spectrum of immune-related disorders [5]. The strongest 
evidence for a causal relationship between the decline of infectious diseases and the 
increase in immunological disorders originates from animal models and a number 
of clinical studies, suggesting the beneficial effect of infectious agents or their 
components known as immunomodulators [5]. Immunomodulators are drugs or 
molecules (Thalidomide. Macrolide antibiotics, and curcumin) that modify the 
dangerous immune response to prevent the inflammatory damage, while leaving the 
protective immune response intact [6]. It is speculated that infections as such are 
important in keeping the immunoregulatory network active and, in the absence of 
such infections, the immune system gets hyperactivated, resulting in allergies and 
autoimmunity [5]. In this regard, the helminth infections need a special mention 
since they were found to be alleviating numerous autoimmune disorders like atopic 
disorders, systemic lupus erythematosus, multiple sclerosis, sepsis, inflammatory 
bowel diseases [7].
Not all infections promote inflammation. While in general, viral and bacterial 
diseases induce inflammation, helminth infections are largely immunosuppres-
sive in nature [3]. The link between fungal and protozoan diseases, with systemic 
inflammation, is not known. In general, infections which promote inflammation 
are thought to augment metabolic diseases while those which dampen inflam-
mation by immunomodulation can confer protection against metabolic diseases 
[3]. Previously, we have shown a decreased prevalence of filarial infection (not 
disease) among both T1DM [8] and T2DM subjects [9]. Further, serum cytokine 
profiling revealed the downregulation of Interleukin-6 (IL-6), Tumour Necrosis 
Factor-alpha (TNF-α) and Granulocyte-Macrophage-Colony Stimulating Factor 
(GM-CSF) and upregulation of Tumour Growth Factor-Beta (TGF-β) in filarial 
positive, compared to filarial negative diabetic subjects [9]. Interestingly, the 
immunomodulatory effect of helminth infection was seen only inT1DM and 
T2DM subjects but not among the coronary artery disease (CAD) patients [10]. 
Even though these were cross-sectional studies, they indicate probable immune-
mediated protection against both T1DM and T2DM by prior filarial infection. 
This also indicates some degree of overlap in the disease pathology between these 
two seemingly different forms of diabetes, which the helminth infection is able 
to target [3, 11]. If this is true, the decreasing incidence of filariasis (due to mass 
drug administration programs) which is being carried globally, can fuel diabetic 
pandemic in future [3, 11]. Thus, childhood infection can either have a beneficial or 
harmful role in determining the susceptibility to T2DM depending upon the nature 
of immune training-induced [3, 11].
2.  Role of innate immune cells in insulin resistance and 
immunomodulation
Traditionally monocytes/macrophages, dendritic cells, Natural killer (NK) 
cells and granulocytes (neutrophils, eosinophils and basophils) together form the 
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cellular arm of innate immunity, since they recognize the pathogen and damage-
associated molecular patterns (PAMPs and DAMPs) [2]. T and B lymphocytes 
together form the cellular arm of the adaptive immunity, since they recognize anti-
gens/epitopes and have immunological memory [2]. During an immune response, 
cells of innate immunity recognize PAMPs and DAMPs through various innate 
immune receptors like Toll-like Receptors (TLRs), NOD-Like Receptors (NLRs), 
RIG-1 Like Receptors (RLRs) and C-Type Lectin Like Receptors (CLRs), etc. and 
get activated. Most of these cells take up the cargo, process them and present them 
to the T cells within the context of MHC [12]. B cells on the other hand take up 
antigens by antibody-mediated endocytosis, process them and present them to the 
T cells [12]. The T cells which recognize these MHC: epitope complexes through 
their T Cell Receptors (TCRs), get activated and secrete cytokines and chemokines 
[12]. These cytokines and chemokines in turn activate and attract more number 
of antigen-presenting cells (APCs), completing the positive feedback loop [12]. 
Thus, antigen processing and presentation and subsequent secretion of cytokines 
and chemokines establish the cross-talks between innate and adaptive immune 
responses, which finally determine the magnitude and nature of the immune 
response [12]. Next, we will look at the role played by specific cell-types in IR and 
immunomodulation.
2.1 Macrophages in insulin resistance and immunomodulation
Out of several immune cell types, macrophages were the earliest to be associated 
with IR [13]. Macrophages are phagocytic cells that serve as the first line of defence 
mechanism against infections [14]. They are of two types: M1 (classically activated) 
and M2 (alternatively activated), which differ in their cytokine secretion and 
functions [14]. The infiltration of macrophages into adipose tissue under conditions 
of obesity-associated IR was reported as early as 1976 [13]. Classically activated or 
CD11c+CD206− M1 macrophages were found to be elevated in visceral adipose tissue 
(VAT) of diet-induced obese (DIO) mice which secrete increased levels of pro-
inflammatory cytokines like TNF-α, IL-1β and IL-6 (Figure 1) [15]. Transcriptional 
profiling of adipose tissue from leptin knock-out mice revealed the upregulation of 
1,304 genes which showed a strong correlation with the body mass index. Of the top 
100 genes which were differentially expressed, 30% were specific for macrophages 
[16]. Resident macrophages in lean mice expressed Macrophage Galactose-binding 
C-type lectin (MGL-1) along with other genes associated with M2 macrophages 
Figure 1. 
Model explaining “Metabolic Hygiene Hypothesis”. Chronic inflammation serves as a link between infections 
and type-2 diabetes. During early stages of the disease, the inflammation is more tissue restricted and primarily 
affects pancreas and target organs of insulin namely skeletal muscle, adipose tissue and liver. This in turn leads 
to pancreatic beta cell loss and insulin resistance, respectively. During latter stages, the inflammation becomes 
more systemic and affects the blood vessels leading to vasculopathies. If small blood vessels are affected, it results 
in microvasculopathies. If larger blood vessels are affected it results to macrovasculopathies. While most viral 
and bacterial infections, can trigger chronic inflammation, helminth infections are unique in attenuating 
inflammation, by means of immunomodulation. Thus, a drastic decrease in helminth infections due to mass 
drug administration can fuel epidemic increase in metabolic diseases.
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(Ym1+, CCR2−, Arg-1+ and IL-10, 15, 16]. With diet-induced obesity, a new popu-
lation of Ym1−, MGL-1−, CCR2+, iNOS+ M1 macrophages were recruited which 
cluster around the necrotic adipocytes forming crown-like structures. While the M1 
macrophages are associated with IR, M2 is more associated with insulin sensitivity 
(Figure 1) [15–17]. In general, peripheral macrophages in newly diagnosed diabetic 
patients are hyporesponsive to inflammatory signals due to the downregulation of 
TLRs [18]. In contrast, macrophages from chronic diabetic patients show chronic 
activation due to constitutive upregulation of B7–1 molecules [19].
With respect to helminth infection, despite the central role played by lympho-
cytes and dendritic cells, the role played by macrophages in both pathology and 
protection cannot be undermined [20]. Helminth products are known to polarize 
macrophages into M2 phenotype which orchestrate fibrosis and wound heal-
ing [21]. Helminth infected macrophages are also termed as nematode-elicited 
macrophages that express a peculiar M2 phenotype [21]. The master cytokines 
involved in M2 polarization are IL-4 and IL-13. The macrophages which are 
polarized by helminth infection express YM1, YM2, Resistin-Like Molecule alpha 
(RELMα) and other markers of M2 phenotype and produce IL-10 [21].Diet-
induced obese mice treated with Litomosoides sigmodontis (Ls) antigen showed 
an increased number of M2 macrophages in the epididymal adipose tissue (EAT) 
inducing a type-2 immune response which improved glucose tolerance (Table 1) 
[22]. Recently, Heligmosomoides polygyrus infected high-fat diet mice showed 
M2 polarization of adipose macrophages which reduced IR [27]. Mice injected 
with Schistosoma mansoni antigens showed significant improvement of metabolic 
control and increased frequency of M2 in HFD mice [28]. HFD mice infected 
with Nippostrongylus brasiliensishad decreased weight gain and improved glucose 
tolerance which was largely due to the polarization of adipose macrophages into 
the M2 phenotype (Table 1) [23].
2.2 Dendritic cells in insulin resistance and immunomodulation
While macrophages are major phagocytic cells, Dendritic cells (DCs) are the 
major antigen-presenting cells that play a crucial role in linking innate and adaptive 
immunity. DCs can interact with both T cells and B cells. Animal studies looking 
at the role of DCs in IR are limited. The CD11c+ myeloid DCs were significantly 
increased in the adipose tissue of obese mice [29]. This suggests that DCs might be 
involved in T cell polarization and activation of macrophages thereby playing an 
important role in adipose inflammation and IR [29]. In the adipose tissue of obese 
mice, there was a substantial increase in the percentage of DCs which was associ-
ated with crown-like structures [30]. Mice lacking DCs (Flt3−/−) had reduced 
number of adipose and liver macrophage content, whereas DC replacement in 
DC-null mice increased liver and adipose macrophage infiltration and IR [30]. Both 
myeloid DCs and plasmacytoid DCs from chronic diabetic patients show upregula-
tion of lineage markers due to high levels of circulating GM-CSF [31].
In helminth infections, DCs are arrested in an immature state characterized by 
an absence/moderate expression of co-stimulatory molecules along with reduced 
pro-inflammatory cytokine secretion [32]. This feature might presumably induce 
the development of a Th2 immune response [33]. While Toll-Like Receptor-
mediated activation brings about DC maturation in general, helminth products 
have evolved alternate pathways of activation which can induce an anti-inflamma-
tory response [34]. Helminth antigen treated dendritic cells produced increased 
levels of IL-4 and IL-10 [35]. Also, human monocyte-derived dendritic cells 
(mhDCs) when infected with live Brugia malayi microfilariae showed downregula-
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cytokines following TLR challenge [36]. Recent research shows that priming of DCs 
with helminth products brings about Th-2 polarization and improves metabolic 
dysregulation [37].
2.3 Neutrophils in insulin resistance and immunomodulation
Neutrophils are microphages which are short-lived phagocytic cells that 
remove and destroy invading microorganisms and also cellular debris [38, 39]. In 
diet-induced obese mice, increased infiltration of neutrophil into adipose tissue 
was reported during weight gain and was associated with IR. In addition to host 
defence, neutrophil-derived serine proteases, such as neutrophil elastase, have been 
implicated in sterile inflammation [40]. Treatment of hepatocytes with neutrophil 
elastase-induced IR (by IRS-1 degradation) while deletion of neutrophil elastase 
in obese mice restored insulin sensitivity [40]. Taken together, neutrophils can be 
added to the extensive repertoire of immune cells that participate in inflammation-
induced IR.
Compared to macrophages the role played by neutrophils in helminth infection 
is well studied [41]. In recent times, like macrophages, neutrophils were shown to 
get polarized either towards classically activated (N1) or alternatively activated 
(N2) phenotypes, following bacterial infections [42]. Whether such polarization 
takes place during helminth infections is not clearly known. Neutrophils were found 
to provide resistance to H. polygyrus infection in vivo and were able to kill the worm 
under in vitro conditions [43]. More recent reports indicate an important role for 
neutrophils in killing the larval stages of Strongyloides stercoralis [44]. Thus there is 
a possibility of neutrophils polarization during helminth infection which might aid 
host metabolism. Haemonchus contortus, a gastric parasite, secretes a 55 kDa secre-
tory glycoprotein (gp55) which binds to CD11b/CD18 integrin present on neutro-
phils and inhibits its action [45].
2.4 Eosinophils in insulin resistance and immunomodulation
Eosinophils are generally associated with allergic responses as seen in parasitic 
infections [46]. While IL-5 serves as the main growth factor for eosinophil develop-
ment, eotaxins (CCL11, CLL24 and CCL26) serve as its major chemotactic factors 
[46]. Activation of eosinophils results in its degranulation on to the target cells 
[46]. They carry eosinophilic granules which are rich in cytotoxic cationic proteins 
including major basic protein (MBP), eosinophil peroxidase (EPO), eosinophilic 
cationic protein (ECP) and eosinophil-derived neurotoxin (EDN) [46]. Adipose 
tissue eosinophils are needed for metabolic homeostasis and are involved in the 
maintenance of alternatively activated macrophages (AAMs) (Figures 1) [47]. 
They serve as the major source of IL-4 which polarizes the macrophages into the M2 
phenotype. Absence of eosinophils can lead to adiposity and systemic IR in obese 
mice [47]. In these animals, IL-5 deficiency leads to loss of eosinophil accumulation 
in the adipose and increased IR [48].
Clinically, helminth infections are the most common cause of persistent 
eosinophilia, wherein they play a vital role in parasitic killing and elimination 
[49]. Ligation of parasite-specific Ig to Fc receptors or direct binding of helminth 
products to TLRs leads to eosinophil activation and degranulation [49]. Activated 
eosinophils bring about worm expulsion in two ways: 1. Direct killing of the worm 
by depositing cytotoxic granules along with reactive oxygen species on to the worm 
membrane and 2. Expulsion/encystment of the dead worm, by coordinating with 
other immune and non-immune cells [49]. However, recent evidence has indicated 
eosinophil activation during helminths infection is an immune evasive strategy 
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favouring the parasite [50]. Eosinophils may influence the immune response in 
a manner that would sustain chronic infection and ensure worm survival [50]. 
Recently, in a high-fat diet mice model, animals infected with Nippostrongylus 
brasiliensis showed sustained metabolic control characterized by decreased fast-
ing glucose and improved insulin sensitivity, which was associated with increased 
eosinophil content in the adipose tissue (Figures 1) [51]. Obese mice injected with 
Litomosoides sigmodontis (Ls) antigen showed an increased number of eosinophils in 
the epididymal adipose tissue which normalized glucose intolerance (Table 1) [22].
2.5 Basophils and mast cells in insulin resistance and immunomodulation
Basophils and mast cells are known for their involvement in allergies and airway 
inflammation [52]. Both cell lineages share a common ancestry: while basophils 
circulate; mast cells remain resident in tissues under normal conditions [52, 53]. 
As like other immune cells, recent studies have implicated them in glucose homeo-
stasis and adipogenesis [54]. VAT from obese mice as well as humans contained a 
significant amount of mast cells [54] Mast cell-deficient mice showed better glucose 
homeostasis with increased metabolic rate [55]. Leptin deficient Ob/Ob mice have 
an increased mast cell content in their adipose tissue and were found to secrete an 
increased amount of TNF-α [56].
Like eosinophils, basophils also serve in the first line of defence mechanism 
against helminth infection [57]. However recently, this concept has been challenged 
for certain helminth infections [58]. The cross-linking of surface IgE on basophils 
by helminth antigens induced IL-4 secretion [59]. Thus, the anti-inflammatory 
Th-2 response is augmented by basophils and mast cells [60]. During helminth 
infections, eosinophils, neutrophils and basophils directly participate in the para-
site killing and expulsion [61]. Basophil deficient mice, infected with L3 larvae of 
Brugia malayi showed decreased eosinophil count, decreased titers of parasite-
specific IgE, reduced CD4+ T cell proliferation and decreased antigen-specific IL-4 
production demonstrating the importance of basophils in the amplification of 
type-2 immune response [62]. Helminth infected mice have an increased number of 
basophils which were capable of priming of Th-2 response [63].
2.6 NK and NKT cells in insulin resistance and immunomodulation
Natural killer (NK) cells are an important component of the innate immune 
response to viral infections and tumours [64]. They have the ability to provide 
an early source of both innate (IL-6 and TNF-α) and adaptive (IFN-γ, IL-4, IL-5 
and IL-13) immune cytokines and can also lyse the target cells through perforin-
granzyme-mediated cytolytic pathway [64]. Natural Killer T (NKT) cells are 
sub-population of lymphocytes that serve as a link between the innate and adaptive 
immunity [65]. They are a heterogeneous group of lymphocytes that share the prop-
erties of both T cells and NK cells. Many of these cells recognize self and foreign 
lipids and glycolipids bound to the non-polymorphic CD1d molecule [65]. Very 
little is known about the role played by NK and NKT cells in metabolic homeostasis 
[66]. VAT obtained from obese subjects was found to have an increased frequency 
of IFN-γ expressing NK cells [67]. The role of iNKT cells in the regulation of 
metabolism is just emerging. Previously, it was found that adipose tissues and liver 
of both mice and humans contain a population of iNKT cells, which decreased with 
increasing adiposity and IR (Figure 2) [68]. In fact, this coincides with the infiltra-
tion of macrophages and T cells into the adipose tissue.
Compared to other cell types, the role played by NK cells in helminth mediated 
immunomodulation is intriguing. NK cells were found to express IL-4 and IL-13 
Inflammation
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in response to microfilaremia but not L3 infection [69]. The early activation of NK 
cells led to apoptosis in response to live L3 exposure, but not to live microfilaremia 
infection [69]. Impairment of NK cell function had a profound effect on worm 
burden and delays the clearance of the parasite. Infection of BALB/c mice with 
L. sigmodontis was shown to suppress the activation of inhibitory receptors but 
promoted the induction of activating receptor on NK cells [70]. NKT cells during 
helminth infections were shown to produce IL-4 as an immunoregulatory cytokine 
when exposed to the nematode glycolipids [71]. Helminths activate both iNKT and 
non-iNKT cells in vivo, enabling them to differentially influence the Th1/Th2 bal-
ance [71]. NKT cells were known to be the early source of IL-4, in the spleen, within 
24 h of L3 B. phangi infection in mice [71].
2.7 Other innate immune cells in insulin resistance and immunomodulation
Myeloid-Derived Suppressor Cells (MDSCs) are heterogenous immature 
myeloid cells which were first discovered in the tumour stroma wherein they were 
found to suppress anti-tumour immune response [72]. Recently, MDSCs were 
shown to alleviate insulin resistance and confer protection against diabetes [73]. 
Adoptive transfer of MDSC cells into HFD mice showed better glucose tolerance 
[74]. Loss of these cells in obese animals aggravated IR [74]. Within the adipose 
tissue milieu, these cells were found to suppress Th1 activation [74]. During hel-
minth infection, anti-proliferative MDSCs emerge which inhibit T cell proliferation 
using eicosanoids generated through 12/15 lipoxygenase pathway [75]. Similarly, 
Schistomes soluble egg antigens were shown to prime MDSC cells which strongly 
inhibited T cell activation [76].
Figure 2. 
Myeloid cell network in Insulin Resistance (IR) and immunomodulation. Helminth infections can bring about 
macrophage polarization from the pro-inflammatory M1 phenotype to anti-inflammatory M2 phenotype. 
They also polarize neutrophils from pro to anti-inflammatory phenotype. They augment both eosinophils and 
basophils which attenuate IR. They induce tolerogenic dendritic cells and myeloid derived suppressor cells 
which inhibit Th1 immunity.
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Nuocytes or Innate lymphoid cells (ILC) are recently discovered innate lym-
phoid cells capable of augmenting other immune cells like helper T cells [77]. ILCs 
are primarily tissue-resident lymphocytes, found in both lymphoid (immune-
associated), and non-lymphoid tissues, and rarely in the peripheral blood (<1%) 
[77, 78]. They are particularly abundant at mucosal surfaces controlling mucosal 
immunity and homeostasis [77, 79]. They differ from other immune cells by the 
absence of regular lymphoid morphology, TCR and BCR rearranged, and expres-
sion of myeloid-specific CD markers [77]. Based on the difference in developmental 
pathways, phenotype, and cytokine secretion, in 2013, ILCs were divided into three 
groups: 1. ILC-1 cells upon priming with IL-12, IL-15 and IL-18 secrete IFN-γ and 
TNF-α; 2. ILC-2 cells upon priming with TSLP, IL-25 and IL-33 a secrete IL-4, IL-5 
and IL-13; 3. ILC-3 cells upon priming with IL-1β, IL-23 and IL-6, secrete IL-17 and 
IL-22 [77]. ILC-1 recruitment into the adipose tissue is directly linked to fat accu-
mulation and exacerbates IR [80], while ILC-2 cells are involved in browning of vis-
ceral adipose tissue [81]. During helminth infection, the early source of IL-13 was 
from nuocytes, through IL-25 and IL-33 dependant priming [82]. Administration 
of Schistosoma mansoni egg-derived ω1 antigen into diabetic mice induced Th-2 
response, which correlated with increased frequency of ICL-2 in adipose tissue, 
which in turn increased the metabolic homeostasis [83].
3. Adaptive immune cells in insulin resistance and immunomodulation
The adaptive immune cells include T cells and B cells which play an important 
role in both IR and immunomodulation.
3.1 T-helper cells in insulin resistance and immunomodulation
T cells are lymphocytes which mature from the thymus (and hence the name) 
and are the major components of the adaptive immune system [84]. They perform 
three major functions: 1. Helper T cells (Th) activate B cells, macrophages, DCs, 
other T cells and other immune cells, 2. Cytotoxic T cells (Tc) directly kill tumour 
cells and pathogen-infected cells and 3. Regulatory T cells (Tregs) maintain 
immune homeostasis [84]. The Th cells are distinguished by their CD4+ phenotype 
and are further classified based on their cytokine profile as 1.Th1 (IFN-γ, IL-2, and 
TNF-β), Th2 (IL-4, IL-5 and IL-13), 3. Th17 (IL-17 and IL-17F), 4.Th9 (IL-9 and 
IL-10), 5.Th22 (IL-22), etc. [84]. T cells in coordination with macrophages and DCs 
fuel VAT inflammation [85]. Both pro-inflammatory cytotoxic T cells (CTLs) and 
interferon-γ (IFN-γ)-producing Th-1 cells contribute to inflammation (Figure 2) 
[86]. On the contrary, VAT-resident Tregs and Th2 cells tend to suppress inflamma-
tion (Figure 2) [87]. Obese IFN-γ-knockout animals, compared with obese wild-
type mice, showed modest improvements in insulin sensitivity, decreased adipocyte 
size, and an M2-macrophage phenotype and cytokine expression [88]. Genetic 
ablation of IL-13 in mice resulted in hyperglycemia, which progressed to hepatic IR 
and systemic metabolic dysfunction [89]. However, studies conducted in our lab on 
serum cytokine profiles in subjects with metabolic syndrome (MS) showed a mixed 
Th1-Th2 response with increased levels of IL-12, IFN-γ, IL-4, IL-5 and IL-13 in 
the serum of subjects with metabolic syndrome (a precondition of diabetes, if not 
already present) [90]. The role of recently discovered Th17 in VAT inflammation 
is still an enigma. Some studies have shown strong pro-inflammatory phenotype 
for these cells inducing IR [91], while our study showed a decline in serum IL-17 
levels in subjects with MS (Figure 2) [92]. The Tregs in VAT has a unique function 
of maintaining immune-homeostasis and improving insulin signalling by PPAR-g 
Inflammation
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activation [93]. The role of other recently identified Th cell subtypes like Th22 and 
Th9 in IR is not clearly known. In general, type-2 diabetic subjects show a mixed 
Th1-Th2 response which becomes more Th1 polarized as the diabetic subjects 
develop microvascular [94] and macrovascular complications [95]. Serum IL-17 
levels are generally low in patients with diabetic nephropathy [96].
T cell-mediated immune responses during filarial infection depend on the 
phase of the infection: 1.The acute phase is skewed towards Th2 (IL-4, IL-5 and 
IL-13) response, 2. The chronic phase is skewed towards “modified Th2 response”, 
with Tregs playing a more prominent compared to Th2 cells and 3. The third 
phase is chronic pathology phase, which is characterized by a drastic shift from 
“modified Th2” response to Th1/Th17 (IFN-γ, IL-2 and IL-17) response, which 
happens only in those who develop lymphatic pathology [97]. Thus, the dif-
ferential immune response seen during various phases of the filarial infection is 
paralleled by the life cycle of the parasite: 1. Microfilaremic stage-predominant 
Th2 response, 2. Adult worm stage- modified Th2-Treg response and 3.Chronic 
pathology stage- Th1/Th17 response [97]. Infection of HFD induced obese mice 
with Heligmosomoides polygyrus, an intestinal nematode parasite, resulted in 
significantly attenuated obesity with marked upregulation of uncoupling protein 
1 (UCP1), a key protein involved in energy expenditure in adipose tissue [98]. 
Further suppression of glucose and triglyceride levels and alteration in the expres-
sion of key genes in the liver involved in lipid metabolism were also seen [98]. An 
augmented helminth induced Th2/Treg response and M2 macrophage polarization 
was characteristic of this attenuated obesity [98].
3.2 Cytotoxic T cells (CTLs) in insulin resistance and immunomodulation
Cytotoxic (CD8+) T cells are one of the effector cells in T-cell mediated immu-
nity which directly kills the target cells (virus or bacteria-infected cells and tumour 
cells). CD8+ T cells were found to migrate into the adipose tissue much before the 
accumulation of macrophage in obese mice [99]. IFN-γ produced by CTLs promotes 
the recruitment and polarization of M1 macrophages (Figure 1) [99]. This results in 
adipose tissue inflammation and IR [99]. In the obese mice, increased infiltration of 
CTLs into the adipose tissue around 22nd week after the initiation of a high-fat diet 
was seen [99]. Antibody-mediated or genetic depletion of CTLs lowered macro-
phage infiltration and adipose inflammation, ameliorating IR [99].
When compared to T-helper cells, the amount of literature available on the 
role of CTLs in helminth infection is limited. Atleast in mice, there is evidence to 
show that CTL population is dispensable for anti-helminth immunity [100]. In 
clinical studies, LF infection was shown to upregulate HLA-A thereby activating 
CTLs [101]. However, these activated CTLs showed poor proliferative response 
under in vitro conditions [101]. The CTL activity was largely seen during lymph-
edema development, rather than acute/modified immune response to helminths 
[101]. Further, these activated CTLs were largely immunomodulatory rather than 
pro-inflammatory in nature [101]. It would be interesting to see whether these 
activated immunosuppressive cells are in fact the recently discovered CD8(+) Tregs 
population (Figure 3).
3.3 B cells in insulin resistance and immunomodulation
B cells form a major component of adaptive immunity and perform two vital 
functions namely: 1. Antigen presentation to T cells which links innate and adaptive 
arms of the immune response and 2. Production of antibodies which perform the 
effector functions. In obese mice, B cells were found to migrate into the adipose 
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tissue shortly after the initiation of a high-fat diet [102]. The initial signal for B 
cell activation is provided by the stressed adipocytes by releasing the self-antigens 
[102]. The activated B cells then induce the activation of pro-inflammatory macro-
phages and T cells and the production of auto-antibodies [102]. Correspondingly, 
increased IgG production (predominantly of IgG2c subtype) and increased IgG+ B 
cells were seen in the VAT of obese mice [102, 103]. B cell null mice showed reduced 
immune cell activation and IR in VAT and transfer of IgG antibodies from obese 
wild type mice to B cell null obese mice worsened glucose tolerance [102]. The IgG 
antibodies, apart from promoting B cell-mediated adipose inflammation, can also 
bind to Fc receptors present on macrophages, NK cells, neutrophils and eosinophils, 
and can bring about cellular activation augmenting inflammation [102, 104]. 
However, recently ZnT8 specific naturally occurring autoantibodies were found to 
be significantly reduced in type-2 diabetes, indicating a beneficial effect for these 
antibodies in reducing IR [26].
The function of B cells in helminth infection is largely restricted to the protective 
Th2 response [97]. IL-4 mediated activation, class switching and affinity matura-
tion of B cells are responsible for the elevated levels of IgE antibodies in infected 
individuals [97]. In streptozotocin-induced diabetic mice, treatment with Brugia 
malayi adult soluble antigen (Bm AS) or microfilarial excretory-secretory antigen 
(Bm mf ES) decreased pancreatic beta-cell destruction [24]. This was due to class 
switching of anti-insulin autoantibodies from IgG2a to IgG1 subtype (Table 1). 
In the same mice model, treatment of diabetic animals with two filarial proteins 
namely recombinant Wuchereria bancrofti L2 (rWbL2) and Brugia malayi abundant 
larval transcript 2 (rBmALT-2), resulted in the augmentation of insulin specific 
IgG1 autoantibodies and normalization of glucose metabolism (Table 1) [25, 105]. 
IL-10-producing B cells also termed as regulatory B cells (Bregs) can dampen inflam-
mation under certain conditions [105]. Thus B cells play contrasting roles in IR and 
Figure 3. 
Lymphoid cell network in Insulin Resistance (IR) and immunomodulation. Helminth infections can bring 
about T cell polarization from the pro-inflammatory Th1 and Th17 phenotype to anti-inflammatory Th2 
phenotype. They also induce proinflammatory ILC-1 and -3 and induce anti-inflammatory ILC-2 cells. They 
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helminth infections; in the context of helminth infections, they orchestrate regula-
tory immune responses via IL-10, whereas in IR they induce adipose inflammation 
via autoantibodies.
4. Conclusion and future directions
A decrease in helminth infections (like lymphatic filariasis) could potentially 
account for the increased prevalence of metabolic diseases in the western world. 
The same immunomodulatory effect can have an impact on type-2 diabetes, as 
was seen in tropical countries. Recently, several helminth antigens were shown to 
confer significant protection against obesity, insulin resistance and diabetes, in 
animal models. The implications of helminth induced immunomodulation are thus 
twofold: Mass drug administration in populations which are highly susceptible to 
type-2 diabetes has to be carried out with care; Secondly, more research is needed 
in identifying and characterizing novel helminth antigens with a strong immuno-
modulatory effect which can later be developed into diabetes vaccines.
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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